For example, the algorithms can now measure the exact volume of blood lost in hemorrhagic strokes from brain CT scans. “Traditionally, doctors use a mathematical formula based on the health condition and the age of the patient to estimate the amount of blood lost,” Yipeng says. The algorithm now provides this vital data in an instant to decide if the patient needs urgent surgery or not.
Infervision started in China in 2016, where it has already partnered with over 140 hospitals. Opening a subsidiary in Germany was the next logical step. The Wiesbaden office will also serve the Spanish, Austrian and Swiss markets, with France and Italy further down the roadmap. “Germany is central to Europe and also enables us to assemble a competitive workforce,” Yipeng explains.
He holds Germany’s workforce and its universities in high esteem: “German engineers are very creative and work hard.” To strengthen its position in Europe, Infervision already plans to make more investments including a dedicated R&D facility in Wiesbaden. “There is huge potential here,” says Yipeng.